SCHEMBL6164065

SCHEMBL6164065

CC1(C)CCc2c(c(-c3ccccc3)nn2-c2ccc(Cl)nn2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.44
RAB9A P51151 1/20 0.44
KDM4E B2RXH2 2/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
ALDH1A1 P00352 4/20 0.36
NPSR1 Q6W5P4 1/20 0.34
PTGS1 P23219 6/20 0.32
ALOX5 P09917 1/20 0.32
PTGS2 P35354 6/20 0.32
OPRM1 P35372 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
LMNA P02545 2/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2D6 P10635 2/20 0.31
CYP2C9 P11712 2/20 0.31
CYP2C19 P33261 2/20 0.31
HTT P42858 2/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6163516 0.90 CCNA2 (0.41) SMN1; SMN2RAB9AKDM4ECCNA2CDK2
SCHEMBL6166808 0.86 RAB9A (0.40) SMN1; SMN2RAB9AKDM4ECCNA2CDK2
SCHEMBL6164846 0.84 CCNA2 (0.38) SMN1; SMN2RAB9ACCNA2CDK2ALDH1A1
SCHEMBL6167319 0.83 RAB9A (0.38) SMN1; SMN2RAB9AKDM4ECCNA2CDK2
SCHEMBL6167058 0.82 KDM4E (0.41) SMN1; SMN2RAB9AKDM4ECCNA2CDK2
SCHEMBL6165092 0.82 CCNA2 (0.38) SMN1; SMN2RAB9ACCNA2CDK2ALDH1A1
SCHEMBL6164821 0.81 CYP1A2 (0.43) SMN1; SMN2RAB9AKDM4ECCNA2CDK2
SCHEMBL6177791 0.80 CCNA2 (0.43) SMN1; SMN2RAB9ACCNA2CDK2ALDH1A1
SCHEMBL6167555 0.74 CCNA2 (0.39) SMN1; SMN2RAB9ACCNA2CDK2
SCHEMBL6166406 0.72 CCNA2 (0.41) SMN1; SMN2RAB9AKDM4ECCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 WO disclosed